Hepatocyte Growth Factor is Associated With Liver Dysfunction and Survival: Biomarker Results of a Phase 2 Study of Proton Beam Therapy in Patients with Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

2017 ◽  
Vol 99 (2) ◽  
pp. S89
Author(s):  
T.S. Hong ◽  
C. Grassberger ◽  
B.Y. Yeap ◽  
J.Y. Wo ◽  
L. Goyal ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Growth Factor ◽  
Hepatocyte Growth Factor ◽  
Proton Beam ◽  
Intrahepatic Cholangiocarcinoma ◽  
Liver Dysfunction ◽  
Proton Beam Therapy ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Hepatocyte Growth

scholarly journals Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma

Hepatology ◽  
2002 ◽  
Vol 36 (5) ◽  
pp. 1089-1097 ◽  
Author(s):  
Julie A. Price ◽  
Stephen J. Kovach ◽  
Timothy Johnson ◽  
Leonidas G. Koniaris ◽  
Paul A. Cahill ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Growth Factor ◽  
Hepatocyte Growth Factor ◽  
Rat Model ◽  
Insulin Like Growth Factor ◽  
Factor I ◽  
Growth Factor I ◽  
Hepatocyte Growth

Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase

1999 ◽  
Vol 30 (3) ◽  
pp. 511-518 ◽  
Author(s):  
Arnaud Monvoisin ◽  
Véronique Neaud ◽  
Victor De Lédinghen ◽  
Liliane Dubuisson ◽  
Charles Balabaud ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Growth Factor ◽  
Hepatocyte Growth Factor ◽  
Direct Evidence ◽  
Carcinoma Cells ◽  
Hepatocellular Carcinoma Cells ◽  
Hepatocyte Growth
Sign in / Sign up

Export Citation Format

Share Document